https://analystgroup.se/kommentarer/kommentar-pa-qlosr-groups-q3-rapport-2/ 2023-11-24T14:18:02+00:00 https://analystgroup.se/kommentarer/kommentar-pa-learning-to-sleeps-q3-rapport/ 2023-11-24T15:40:30+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-q3-rapport-4/ 2023-11-29T13:20:06+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-q3-rapport-3/ 2023-11-30T12:35:07+00:00 https://analystgroup.se/kommentarer/kommentar-pa-nosiums-q3-rapport-3/ 2023-11-30T13:02:17+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-delarsrapport/ 2023-11-30T13:23:52+00:00 https://analystgroup.se/kommentarer/kommentar-pa-fineparts-q3-rapport-2/ 2023-11-30T14:11:37+00:00 https://analystgroup.se/kommentarer/comment-on-fluicells-q3-23-report/ 2023-12-01T10:28:38+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-gabathers-samarbete-med-mindig/ 2023-12-11T14:23:16+00:00 https://analystgroup.se/kommentarer/gabather-inleder-diskussioner-med-forskare-vid-karonlinska-institut/ 2023-12-14T11:57:51+00:00 https://analystgroup.se/kommentarer/comment-on-stenocare-expanding-in-australia/ 2023-12-14T15:13:17+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-qbricks-dotterbolag-ritualen-slutavrakning-om-23-msek/ 2023-12-15T09:31:07+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-astor-groups-order-om-ca-22-msek/ 2023-12-18T13:46:37+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-qbricks-order-fran-norwegian/ 2023-12-20T12:36:54+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-ranlos-senaste-statusuppdatering-och-pipeline-for-ar-2024/ 2023-12-22T08:34:09+00:00 https://analystgroup.se/kommentarer/kommenter-pa-lyckegards-renodling-av-verksamheten/ 2024-01-08T12:30:25+00:00 https://analystgroup.se/kommentarer/comment-on-huddlestocks-new-letter-of-intent/ 2024-01-10T12:29:44+00:00 https://analystgroup.se/kommentarer/comment-on-eevias-reorganized-distribution-in-north-america-and-new-order/ 2024-01-10T15:18:38+00:00 https://analystgroup.se/kommentarer/comment-on-eevia-entering-negotiations-for-a-significant-sales-contract-for-2025-with-an-option-to-extend-until-2027/ 2024-01-12T11:26:08+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-helarsrapport-2/ 2024-01-25T14:04:00+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-chargepanels-foretradesemission-och-senaste-avtal/ 2024-02-12T11:39:17+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-windon-blir-exklusiv-distributor-for-ridgeblade/ 2024-02-13T14:59:39+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-q4-rapport-3/ 2024-02-14T10:37:37+00:00 https://analystgroup.se/kommentarer/kommentar-pa-sds-q4-rapport-2/ 2024-02-15T14:35:48+00:00 https://analystgroup.se/kommentarer/comment-on-eevia-healths-q4-report/ 2024-02-15T14:51:03+00:00 https://analystgroup.se/kommentarer/kommentar-pa-obducats-q4-rapport-5/ 2024-02-16T14:53:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-arctic-blue-beverages-q4-rapport-2/ 2024-02-19T13:13:25+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-q4-rapport-3/ 2024-02-20T12:27:05+00:00 https://analystgroup.se/kommentarer/kommentar-pa-syncro-groups-q4-rapport-2/ 2024-02-21T10:42:07+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-q4-rapport-2/ 2024-02-21T20:28:56+00:00 https://analystgroup.se/kommentarer/kommentar-pa-nosiums-q4-rapport-3/ 2024-02-22T11:50:58+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-year-end-report-2023/ 2024-02-22T13:35:04+00:00 https://analystgroup.se/kommentarer/comment-on-huddlestockss-q4-23-report/ 2024-02-22T14:35:36+00:00 https://analystgroup.se/kommentarer/kommentar-pa-first-ventures-q4-rapport-3/ 2024-02-22T14:56:01+00:00 https://analystgroup.se/kommentarer/kommentar-pa-gold-town-games-q4-rapport-3/ 2024-02-23T08:43:11+00:00 https://analystgroup.se/kommentarer/kommentar-pa-maven-wireless-q4-rapport-3/ 2024-02-23T12:02:53+00:00 https://analystgroup.se/kommentarer/analyst-group-comments-on-bjorn-borgs-year-end-report-for-2023/ 2024-02-23T15:25:37+00:00 https://analystgroup.se/kommentarer/kommentar-pa-astor-groups-q4-rapport/ 2024-02-26T14:49:00+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ranlos-bokslutskommunike/ 2024-02-26T15:37:48+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tcecurs-q4-rapport-4/ 2024-02-27T11:26:59+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-q4-rapport-4/ 2024-02-28T11:41:17+00:00 https://analystgroup.se/kommentarer/kommentar-pa-aptahems-q4-rapport-4/ 2024-02-29T12:35:11+00:00 https://analystgroup.se/kommentarer/kommentar-pa-windon-energy-groups-q4-rapport/ 2024-02-29T13:17:50+00:00 https://analystgroup.se/kommentarer/comment-on-pharma-equity-groups-notification-from-the-epo-granting-their-patent-for-the-drug-candidate-rnx-022/ 2024-03-05T11:22:09+00:00 https://analystgroup.se/kommentarer/kommentar-avseende-distributorsavtalet-for-ridgeblade/ 2024-03-07T15:54:39+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-zoomabilitys-jv-avtal-i-kina/ 2024-03-08T16:08:53+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lucky-games-q4-23/ 2024-03-11T08:26:16+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-lyckegards-ingangna-avtal-om-villkorad-overlatelse-av-aktier-i-lyckegard-soil-seed-ab/ 2024-03-14T11:51:14+00:00 https://analystgroup.se/kommentarer/kommentar-pa-chargepanels-q4-rapport/ 2024-03-18T13:43:35+00:00 https://analystgroup.se/kommentarer/comment-on-eevia-receiving-a-grant-of-approx-sek-2-7m-and-multiple-orders-totaling-approx-sek-2-0m/ 2024-03-19T12:52:50+00:00 https://analystgroup.se/kommentarer/analyst-group-comments-on-pegs-year-end-report-for-2023/ 2024-03-20T12:57:21+00:00 https://analystgroup.se/kommentarer/comment-on-huddlestocks-technology-used-in-stackby-mes-new-fund-trading-app/ 2024-03-22T11:38:17+00:00 https://analystgroup.se/kommentarer/comment-on-movinns-annual-report/ 2024-03-22T13:55:29+00:00 https://analystgroup.se/kommentarer/kommentar-pa-windons-expansion-pa-den-norska-marknaden-genom-ett-nytt-partnerskap/ 2024-03-27T11:53:19+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lyckegards-q4-rapport/ 2024-03-29T11:20:02+00:00 https://analystgroup.se/kommentarer/comment-on-pharma-equity-groups-positive-final-results-from-the-phase-ii-trial-of-the-drug-candidate-rnx-051/ 2024-04-05T12:08:14+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-astor-groups-avtal-om-forvarv-av-airsafe-och-genomforda-riktade-nyemission-om-70-msek/ 2024-04-10T14:04:32+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-jv-avtal-i-kina/ 2024-04-11T11:57:52+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-order-avseende-iadr-dice-shakers/ 2024-04-18T09:39:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-arctic-blue-beverages-nya-lansering-inom-ready-to-drink-segmentet-samt-nya-erhallna-lan-om-totalt-eur-150k/ 2024-04-19T09:52:44+00:00 https://analystgroup.se/kommentarer/kommentar-pa-mavens-produktionsavtal-med-vexos-inc/ 2024-04-24T07:05:49+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-q1-rapport-3/ 2024-04-26T12:19:09+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-finansierings-och-licensavtal-med-unidaco/ 2024-04-29T12:27:31+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-mti-investments-nya-aktieagarlan-till-aml-finance-limited/ 2024-05-01T17:15:22+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-q1-report-report-2024/ 2024-05-02T10:05:08+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-q1-rapport-2/ 2024-05-03T07:06:28+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-mti-investments-avtal-om-att-utoka-agarandelen-i-fintech-africa-ab/ 2024-05-03T09:17:58+00:00 https://analystgroup.se/kommentarer/kommentar-pa-obducats-q1-rapport-4/ 2024-05-06T07:02:21+00:00 https://analystgroup.se/kommentarer/kommentar-pa-sds-q1-rapport-2024/ 2024-05-06T12:43:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-q1-rapport-3/ 2024-05-10T08:57:36+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lyckegards-q1-rapport/ 2024-05-13T07:30:28+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tcecurs-q1-rapport-4/ 2024-05-14T07:54:09+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-q1-rapport-3/ 2024-05-14T08:04:59+00:00 https://analystgroup.se/kommentarer/kommentar-pa-chargepanels-q1-rapport-2/ 2024-05-14T12:51:29+00:00 https://analystgroup.se/kommentarer/kommentar-pa-arctic-blue-beverages-q1-rapport/ 2024-05-15T11:37:18+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-q1-rapport-3/ 2024-05-16T06:57:12+00:00 https://analystgroup.se/kommentarer/kommentar-pa-first-ventures-q1-rapport-2/ 2024-05-16T09:07:42+00:00 https://analystgroup.se/kommentarer/comment-on-pegs-q1-report-for-2024/ 2024-05-16T10:34:11+00:00 https://analystgroup.se/kommentarer/comment-on-bjorn-borgs-q1-report-for-2024/ 2024-05-17T09:14:20+00:00 https://analystgroup.se/kommentarer/analyst-group-inleder-analysbevakning-pa-luxbright/ 2024-05-20T11:50:21+00:00 https://analystgroup.se/kommentarer/kommentar-pa-nosiums-q1-rapport-3/ 2024-05-28T10:15:59+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-refinansiering/ 2024-05-30T09:18:41+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-samarbete-med-l3harris-vart-over-15-msek/ 2024-05-30T09:28:19+00:00 https://analystgroup.se/kommentarer/kommentar-pa-windon-energy-groups-q1-rapport/ 2024-05-30T11:37:29+00:00 https://analystgroup.se/kommentarer/comment-on-huddlestockss-q1-24-report/ 2024-05-30T12:16:32+00:00 https://analystgroup.se/kommentarer/kommentar-pa-syncro-groups-q1-rapport-3/ 2024-05-30T13:09:21+00:00 https://analystgroup.se/kommentarer/comment-on-odi-pharmas-quarterly-report/ 2024-05-30T13:20:10+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lucky-games-rapport/ 2024-06-03T10:56:25+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-windons-lansering-av-de-forsta-demoanlaggningarna-for-ridgeblade/ 2024-06-03T11:03:59+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-senaste-kapitaltillskott/ 2024-06-03T13:43:01+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-storsta-enskilda-order-genom-ett-nytt-samarbete-med-stena-recycling-danmark/ 2024-06-10T08:36:27+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-treariga-avtal-med-en-ledande-fordonstillverkare-vart-lagst-132-msek/ 2024-06-12T08:20:56+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-annonserade-foretradesemission-om-ca-15-msek/ 2024-06-14T08:03:59+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-expansion-into-canada/ 2024-06-17T13:01:34+00:00 https://analystgroup.se/kommentarer/comment-on-odi-pharmas-strategic-market-entry-to-switzerland/ 2024-06-26T10:25:02+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-term-sheet-avseende-forlaggande-av-det-oannonserade-flaggskeppsspelet-med-en-europeisk-spelforlaggare/ 2024-07-01T07:58:31+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-windons-order-om-24-msek/ 2024-07-02T09:20:14+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-luxbright-godkanda-resultat-och-leverans-av-ett-forsta-kundspecifikt-rontgenror-samt-tillhorande-efterfoljningsorder/ 2024-07-02T09:25:43+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-refine-groups-dotterbolag-gasoltubens-nya-logistikanlaggning/ 2024-07-03T08:25:16+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-forlagsavtal-med-en-europeisk-spelforlaggare-avseende-det-oannonserade-flaggskeppsspelet/ 2024-07-26T08:33:12+00:00 https://analystgroup.se/kommentarer/kommentar-pa-obducats-q2-rapport/ 2024-07-30T09:35:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-lakemedel-zeqmelit-som-har-registrerats-som-varumarke-i-usa/ 2024-08-08T11:39:01+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-jv-avtal-med-ouhua-ruihe/ 2024-08-12T12:58:28+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-q2-rapport-4/ 2024-08-14T09:52:40+00:00 https://analystgroup.se/kommentarer/comment-on-pegs-q2-report-for-2024/ 2024-08-16T11:44:04+00:00 https://analystgroup.se/kommentarer/comment-on-bjorn-borgs-q2-report-for-2024/ 2024-08-16T13:58:05+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lyckegards-q2-rapport-2/ 2024-08-20T13:16:29+00:00 https://analystgroup.se/kommentarer/kommentar-pa-arctic-blue-beverages-q2-rapport-3/ 2024-08-21T11:01:11+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-q2-rapport-2/ 2024-08-21T13:16:07+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-q2-report-report-2024/ 2024-08-22T06:20:19+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-tillkannagivande-av-flaggskeppstiteln-hela-tillsammans-med-dess-forlaggare-knights-peak/ 2024-08-22T07:05:30+00:00 https://analystgroup.se/kommentarer/kommentar-pa-first-ventures-q2-rapport-2/ 2024-08-22T14:02:59+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-q2-rapport/ 2024-08-23T09:43:25+00:00 https://analystgroup.se/kommentarer/kommentar-pa-refine-q2-rapport-2024/ 2024-08-23T12:37:06+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-h1-rapport/ 2024-08-23T12:42:55+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-q2-rapport-3/ 2024-08-23T13:08:15+00:00 https://analystgroup.se/kommentarer/kommentar-pa-embark-groups-rapport/ 2024-08-26T07:01:03+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tcecurs-q2-rapport-3/ 2024-08-27T11:40:43+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-q2-rapport-3/ 2024-08-29T06:55:19+00:00 https://analystgroup.se/kommentarer/comment-on-odi-pharmas-quarterly-report-2/ 2024-08-29T13:21:12+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-q2-rapport-5/ 2024-08-30T13:30:02+00:00 https://analystgroup.se/kommentarer/kommentar-pa-syncro-groups-q2-rapport-3/ 2024-09-05T12:31:37+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-leverans-av-rontgenkallor-utrustade-med-luxbrights-rontgenror-till-en-amerikansk-tillverkare-av-industriella-ct-system/ 2024-09-09T13:21:25+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-tcecur-utser-per-lindstrand-till-ny-vd-och-koncernchef/ 2024-09-25T06:07:19+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-verksamhetsuppdatering-och-kapitalanskaffning/ 2024-09-27T07:33:11+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-uppdaterade-nav-avseende-leonardo-b/ 2024-09-27T13:12:42+00:00 https://analystgroup.se/kommentarer/kommentar-pa-refine-groups-nyhet-om-folkhemmet/ 2024-10-01T09:35:08+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-sectragon-international-integreras-i-awt/ 2024-10-02T09:23:26+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-acucort-beviljas-forlangd-sme-status-av-ema-den-nordiska-lanseringen-av-zeqmelit-samt-den-stundande-medverkan-pa-ispor-i-barcelona/ 2024-10-02T11:31:38+00:00 https://analystgroup.se/kommentarer/kommentar-pa-movebybikes-oppnande-av-ny-logistikhub-i-stockholm/ 2024-10-03T14:04:53+00:00 https://analystgroup.se/kommentarer/kommentar-pa-astor-groups-nyforvarvade-scandiflashs-order-om-42-musd/ 2024-10-07T06:56:48+00:00 https://analystgroup.se/kommentarer/comment-on-pharma-equity-groups-directed-share-issue-to-a-premium/ 2024-10-07T07:00:11+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-kinda-brave-erhallit-den-andra-milstolpsbetalningen-avseende-utvecklingen-av-hela/ 2024-10-10T11:55:26+00:00 https://analystgroup.se/kommentarer/kommentar-pa-movebybikes-reklamaffar-med-airmee/ 2024-10-10T13:42:19+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-updated-guidance-for-2024/ 2024-10-14T11:37:21+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-lansering-av-en-ny-rontgenkalla-ix1-vilken-kommer-att-presenteras-pa-en-internationell-massa-i-las-vegas/ 2024-10-15T14:18:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-forlagsavtal-med-aurora-punks-avseende-spelet-distant-bloom-pa-bade-pc-och-konsol/ 2024-10-17T07:14:47+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-utfall-avseende-nyttjande-av-teckningsoptioner-av-serie-to-6-b/ 2024-10-17T11:18:04+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-senaste-nyheter-och-foretradesemission/ 2024-10-21T07:41:14+00:00 https://analystgroup.se/kommentarer/kommentar-pa-refine-groups-forsaljning-av-sqrtn-company-ab/ 2024-10-21T09:24:08+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-vunnna-upphandlingar-pa-systembolaget/ 2024-10-21T12:49:10+00:00 https://analystgroup.se/kommentarer/comment-on-pharma-equity-groups-obtained-patent-protection-in-japan-for-rnx-051/ 2024-10-23T10:00:50+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-q3-rapport-2/ 2024-10-24T11:09:48+00:00 https://analystgroup.se/kommentarer/kommentar-pa-movebybikes-senaste-reklamaffar/ 2024-10-25T09:11:21+00:00 https://analystgroup.se/kommentarer/%c2%accomment-on-odi-pharmas-announcement-of-rights-issue/ 2024-10-31T09:10:10+00:00 https://analystgroup.se/kommentarer/comment-on-irisitys-q3-report/ 2024-11-05T11:54:49+00:00 https://analystgroup.se/kommentarer/kommentar-pa-movebybikes-utokade-samarbete-med-airmee/ 2024-11-05T12:01:00+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-q3-report-report-2024/ 2024-11-06T09:57:27+00:00 https://analystgroup.se/kommentarer/kommentar-paramlosa-shipping/ 2024-11-07T13:45:16+00:00 https://analystgroup.se/kommentarer/kommentar-pa-refine-groups-q3-rapport-2024/ 2024-11-08T15:20:08+00:00 https://analystgroup.se/kommentarer/kommentar-pa-obducats-q3-rapport-5/ 2024-11-11T13:38:57+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-samtliga-patienter-har-genomgatt-acucorts-fas-4-studie-zeq001/ 2024-11-13T13:06:12+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-q3-rapport-2024/ 2024-11-14T13:21:32+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-q3-rapport-4/ 2024-11-14T15:52:30+00:00 https://analystgroup.se/kommentarer/comments-on-bjorn-borgs-q3-report-for-2024/ 2024-11-15T09:37:03+00:00 https://analystgroup.se/kommentarer/comment-on-pegs-q3-report-for-2024/ 2024-11-15T11:49:06+00:00 https://analystgroup.se/kommentarer/comment-on-the-danish-health-ministers-decision-to-propose-a-permanent-legalization-of-medical-cannabis/ 2024-11-20T08:17:25+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-verksamhetsuppdatering/ 2024-11-20T08:35:39+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-forlagsavtal-med-aurora-punks-avseende-spelet-go-fight-fantastic/ 2024-11-21T08:01:41+00:00 https://analystgroup.se/kommentarer/kommentar-pa-first-ventures-q3-rapport-3/ 2024-11-21T10:59:52+00:00 https://analystgroup.se/kommentarer/kommentar-pa-embark-groups-q3-rapport/ 2024-11-25T07:56:36+00:00 https://analystgroup.se/kommentarer/comment-on-odi-pharmas-quarterly-report-3/ 2024-11-25T14:02:02+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-q3-rapport/ 2024-11-25T14:41:32+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-medverkan-pa-den-vetenskapliga-konferensen-ispor-i-barcelona/ 2024-11-26T10:25:08+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-q3-rapport/ 2024-11-26T17:27:12+00:00 https://analystgroup.se/kommentarer/comment-on-stenocare-shifting-strategy-to-focus-on-trading-and-exit-from-production/ 2024-11-27T12:35:16+00:00 https://analystgroup.se/kommentarer/kommentar-pa-movebybikes-q3-rapport/ 2024-11-27T14:55:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-senaste-nyheter-om-zoom-stick/ 2024-11-27T15:04:55+00:00 https://analystgroup.se/kommentarer/analyst-group-inleder-bevakning/ 2024-11-28T08:01:55+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-q3-rapport-4/ 2024-11-28T11:58:04+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-q3-rapport-5/ 2024-11-29T12:42:09+00:00 https://analystgroup.se/kommentarer/comment-on-the-outcome-of-irisitys-rights-issue/ 2024-11-29T13:56:54+00:00 https://analystgroup.se/kommentarer/comment-on-that-stenocares-astrum-oil-has-been-approved-for-sales-in-norway/ 2024-12-02T10:26:22+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-q3-rapport-samt-foretradesemission/ 2024-12-04T08:35:18+00:00 https://analystgroup.se/kommentarer/comment-on-odi-pharmas-update-on-polands-expanding-medical-cannabis-market/ 2024-12-04T16:03:27+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-utvecklingsavtal-med-tech-macau-ltd/ 2024-12-10T16:15:24+00:00 https://analystgroup.se/kommentarer/comment-on-pharma-equity-groups-new-execution-strategy/ 2024-12-13T13:49:17+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-approval-for-a-new-medical-cannabis-cbd100-oil/ 2024-12-17T09:25:41+00:00 https://analystgroup.se/kommentarer/kommentar-pa-titanias-forvarv-av-byggmastaren-2-i-solna/ 2024-12-17T13:48:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-obducats-senaste-ordrar/ 2024-12-18T15:16:30+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-inlamnade-ipsp-ansokan-till-fda/ 2024-12-19T10:51:48+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-announcement-of-a-conditional-rights-issue-of-up-to-dkk-20-2m/ 2024-12-20T10:36:11+00:00 https://analystgroup.se/kommentarer/kommentar-pa-neovicis-avtal-om-forvarv-av-wraptech-och-upptaget-lan-om-11-msek/ 2024-12-23T10:53:59+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-omvanda-forvarv-av-co-properties/ 2024-12-27T14:06:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-sakerstallda-finansiering-fram-till-lanseringen-av-hela-samt-det-okade-globala-intresset-for-flaggskeppstiteln/ 2025-01-03T07:38:45+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-typgodkannande-for-en-ny-rormodell-och-nya-ordrar-om-1-msek-fran-fisica-inc/ 2025-01-10T14:37:25+00:00 https://analystgroup.se/kommentarer/comment-on-the-outcome-of-stenocares-conditional-rights-issue/ 2025-01-22T15:23:07+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-investering-i-capito-capital-a-s/ 2025-01-28T07:34:07+00:00 https://analystgroup.se/kommentarer/comment-on-eevia-healths-new-orders-of-sek-763k-eur-66k-and-newly-acquired-customer/ 2025-01-29T12:04:55+00:00 https://analystgroup.se/kommentarer/kommentar-pa-nosa-plugs-lansering-av-nosa-nozoil/ 2025-01-29T15:31:14+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-utfallet-i-acucorts-foretradesemission-samt-positiva-resultat-fran-fas-iv-studie/ 2025-02-04T07:48:15+00:00 https://analystgroup.se/kommentarer/comment-on-eevia-healths-divestment-of-the-eye-health-candidate-retinari/ 2025-02-05T09:14:39+00:00 https://analystgroup.se/kommentarer/comment-on-eevia-healths-q4-report-2/ 2025-02-06T14:38:50+00:00 https://analystgroup.se/kommentarer/analyst-group-inleder-analysbevakning-pa-hifab-och-kommenterar-hifabs-q4-rapport/ 2025-02-11T13:14:08+00:00 https://analystgroup.se/kommentarer/comment-on-eevia-healths-new-sales-orders-totaling-sek-619k-eur-54k-and-participation-in-leading-trade-fair-biofach/ 2025-02-11T16:11:04+00:00 https://analystgroup.se/kommentarer/comment-on-eevia-healths-term-sheet-agreement-with-an-international-partner-and-the-announced-insider-transactions/ 2025-02-12T14:08:57+00:00 https://analystgroup.se/kommentarer/comment-on-eevia-healths-initiated-divestment-of-assets-related-to-berry-extract-manufacturing/ 2025-02-13T13:47:51+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-q4-rapport-2024/ 2025-02-14T08:55:15+00:00 https://analystgroup.se/kommentarer/kommentar-pa-nosa-plugs-q4-rapport/ 2025-02-14T10:29:02+00:00 https://analystgroup.se/kommentarer/comments-on-nosa-plugs-q4-report/ 2025-02-14T11:05:51+00:00 https://analystgroup.se/kommentarer/comment-on-stenocare-launching-next-generation-medical-cannabis-oil-product-in-australia/ 2025-02-14T11:12:56+00:00 https://analystgroup.se/kommentarer/kommentar-pa-obducats-q4-rapport-och-foretradesemisson/ 2025-02-17T11:35:20+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-q4-rapport-4/ 2025-02-18T13:47:45+00:00 https://analystgroup.se/kommentarer/kommentar-pa-titanias-q4-rapport/ 2025-02-20T11:45:25+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-q4-rapport-3/ 2025-02-20T12:52:03+00:00 https://analystgroup.se/kommentarer/kommentar-pa-first-ventures-q4-rapport-4/ 2025-02-20T15:44:26+00:00 https://analystgroup.se/kommentarer/analyst-group-inleder-analysbevakning-pa-cedergrenska-och-kommenterar-cedergrenskas-q2-rapport-for-ar-2024-25/ 2025-02-21T08:54:28+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-bokslutskommunike-for-ar-2024/ 2025-02-21T10:16:07+00:00 https://analystgroup.se/kommentarer/comment-on-bjorn-borgs-year-end-report-for-2024/ 2025-02-21T11:09:45+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-q4-rapport-4/ 2025-02-24T10:50:39+00:00 https://analystgroup.se/kommentarer/kommentar-pa-refine-q4-rapport-2024/ 2025-02-24T14:44:26+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-q4-rapport/ 2025-02-25T15:48:06+00:00 https://analystgroup.se/kommentarer/analyst-group-initiates-equity-research-coverage-and-comments-on-hydrogenpros-q4-2024-report/ 2025-02-26T10:59:47+00:00 https://analystgroup.se/kommentarer/analyst-group-initiates-equity-research-coverage-and-comments-on-genetic-analysis-q4-24-report/ 2025-02-27T08:00:25+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-q4-rapport-5/ 2025-02-27T12:37:27+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-q4-report-report-2024/ 2025-02-27T14:43:45+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-q4-rapport/ 2025-02-28T13:54:17+00:00 https://analystgroup.se/kommentarer/kommentar-pa-neovicis-q4-rapport/ 2025-02-28T16:15:35+00:00 https://analystgroup.se/kommentarer/comment-on-odi-pharmas-quarterly-report-4/ 2025-03-03T09:17:06+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-q4-rapport/ 2025-03-03T12:30:22+00:00 https://analystgroup.se/kommentarer/kommentar-pa-hifabs-senaste-ramavtal/ 2025-03-04T10:47:53+00:00 https://analystgroup.se/kommentarer/kommentar-pa-emb-mission-bounds-avsiktsforklaring-om-forvarv-fran-confetti-group/ 2025-03-05T07:52:34+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-lansering-av-go-fight-fantastic-pa-konsol-den-6-mars/ 2025-03-06T13:26:18+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-forlangda-samarbetsavtal-med-vj-x-ray/ 2025-03-10T14:59:23+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-refine-groups-avyttring-av-ecomm-och-indirekt-gasoltuben/ 2025-03-11T15:06:45+00:00 https://analystgroup.se/kommentarer/kommentar-pa-cedergrenskas-initiativ-for-att-optimera-kapitalstrukturen-extra-utdelning-samt-aterkopsprogram/ 2025-03-12T14:30:16+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-ytterligare-typgodkannande-fran-fisica-inc/ 2025-03-19T13:38:01+00:00 https://analystgroup.se/kommentarer/comment-on-pegs-year-end-report-for-2024/ 2025-03-20T12:31:31+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-cedergrenska-erhaller-fyra-positiva-besked-fran-skolinspektionen/ 2025-03-21T10:45:54+00:00 https://analystgroup.se/kommentarer/kommentar-pa-emb-mission-bounds-q4-rapport/ 2025-03-21T12:56:48+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-launch-of-nosa-nozoil-in-germany/ 2025-03-25T07:35:41+00:00 https://analystgroup.se/kommentarer/analyst-group-comments-on-irisitys-q4-report-for-2024/ 2025-03-26T08:41:07+00:00 https://analystgroup.se/kommentarer/kommentar-pa-neovicis-nyhet-om-expansion-till-asien/ 2025-03-26T10:28:54+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-lansering-av-distant-bloom-pa-konsol/ 2025-03-27T10:30:32+00:00 https://analystgroup.se/kommentarer/kommentar-pa-obducats-inkopsorder-om-32-msek-fran-befintlig-produktionsservice-kund/ 2025-03-28T11:31:47+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-nya-order-pa-zeqmelit-samt-expansion-i-danmark/ 2025-04-02T08:23:50+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-achieving-positive-cash-flow-in-q1-2025/ 2025-04-02T09:17:34+00:00 https://analystgroup.se/kommentarer/comment-on-stenocare-astrum-10-10-oil-being-approved-for-reimbursement-in-germany/ 2025-04-04T06:54:12+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-forvarv-av-thbc/ 2025-04-07T14:19:27+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-omsattningsmal-om-100-130-msek-ar-2026/ 2025-04-11T07:23:46+00:00 https://analystgroup.se/kommentarer/kommentar-pa-titanias-hyresavtal-med-stc-i-ragsved-samt-markanvisningsavtal-med-solna-stad/ 2025-04-11T15:04:52+00:00 https://analystgroup.se/kommentarer/comment-on-genetic-analysis-launch-of-a-consumer-test-to-the-chinese-market/ 2025-04-22T14:04:53+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-annonserade-foretradesemission-om-ca-15-msek-2/ 2025-04-23T07:44:19+00:00 https://analystgroup.se/kommentarer/kommentar-pa-hifabs-q1-rapport/ 2025-04-23T11:03:16+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-avsiktsforklaring-med-hockeyettan/ 2025-04-24T13:19:57+00:00 https://analystgroup.se/kommentarer/kommentar-pa-cedergrenskas-forvarv-av-skargardsgymnasiet-i-norrtalje/ 2025-04-28T14:26:05+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-exklusiva-samarbetsavtal-med-ett-sydkoreanskt-utvecklingsbolag-avseende-utvecklingen-av-kallkatodbaserade-rontgenror/ 2025-04-30T06:40:11+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-ingangna-avtal-om-forsaljning-av-fartyget-perseus/ 2025-05-05T06:36:44+00:00 https://analystgroup.se/kommentarer/comment-on-genetic-analysis-directed-share-issue-of-nok-12-8m/ 2025-05-05T11:56:34+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-q1-rapport-4/ 2025-05-08T10:21:37+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-q1-report-2025/ 2025-05-08T15:06:01+00:00 https://analystgroup.se/kommentarer/kommentar-pa-kinda-braves-q1-rapport/ 2025-05-09T11:32:43+00:00 https://analystgroup.se/kommentarer/kommentar-pa-obducats-q1-rapport-5/ 2025-05-09T14:36:03+00:00 https://analystgroup.se/kommentarer/kommentar-pa-cedergrenskas-omvanda-vinstvarning-for-det-tredje-kvartalet-2024-25/ 2025-05-12T13:27:44+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-nya-order-pa-zeqmelit/ 2025-05-13T08:13:08+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-q1-rapport-3/ 2025-05-13T12:57:31+00:00 https://analystgroup.se/kommentarer/comment-on-irisitys-q1-report-for-2025/ 2025-05-14T07:45:28+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-q1-rapport-4/ 2025-05-14T10:59:55+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-q1-rapport-4/ 2025-05-14T11:26:25+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-q1-report/ 2025-05-15T08:50:30+00:00 https://analystgroup.se/kommentarer/kommentar-pa-first-ventures-q1-rapport-3/ 2025-05-15T13:07:58+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-q1-rapport-2025/ 2025-05-15T14:23:19+00:00 https://analystgroup.se/kommentarer/kommentar-pa-titanias-q1-rapport/ 2025-05-15T15:06:51+00:00 https://analystgroup.se/kommentarer/comment-on-hydrogenpros-q1-report/ 2025-05-16T09:41:29+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-nya-order-om-03-msek-fran-vj-x-ray/ 2025-05-19T07:32:52+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-order-om-05-msek-avseende-en-anpassad-modell-av-luxbrights-ix1-rontgenkalla/ 2025-05-20T12:22:09+00:00 https://analystgroup.se/kommentarer/kommentar-pa-cedergrenskas-q3-rapport-for-ar-2024-25/ 2025-05-23T09:27:07+00:00 https://analystgroup.se/kommentarer/kommentar-pa-emb-mission-bounds-q1-rapport/ 2025-05-23T13:12:33+00:00 https://analystgroup.se/kommentarer/analyst-group-comments-on-nosa-plugs-expansion-into-norway-through-distributor-agreement/ 2025-05-23T13:17:43+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-lakemedel-zeqmelit-som-har-registrerats-som-varumarke-i-kanada/ 2025-05-26T13:21:43+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-q1-rapport/ 2025-05-27T12:48:06+00:00 https://analystgroup.se/kommentarer/comment-on-genetic-analysis-q1-report-report-2025/ 2025-05-28T06:14:36+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-cinis-har-skickat-ytterligare-en-full-fartygslast-med-kaliumsulfat/ 2025-05-28T10:12:18+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-annonserade-foretradesemission-om-ca-134-msek/ 2025-05-28T10:55:46+00:00 https://analystgroup.se/kommentarer/comment-on-pharma-equity-groups-new-strategy-to-drive-growth-and-shareholder-returns/ 2025-05-30T08:41:59+00:00 https://analystgroup.se/kommentarer/kommentar-pa-neovicis-q1-rapport/ 2025-06-02T08:35:18+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-q1-rapport-4/ 2025-06-02T12:28:14+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-order-om-04-msek-avseende-en-ny-modell-av-blixtrontgenror/ 2025-06-02T14:09:00+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-avsiktsforklaring-loi-med-lunatus-avseende-mellanostern-och-gulfstaterna/ 2025-06-10T08:11:58+00:00 https://analystgroup.se/kommentarer/kommentar-pa-utfallet-i-luxbrights-foretradesemission/ 2025-06-12T10:27:02+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-titania-har-byggstartat-i-hallunda-gard/ 2025-06-16T12:22:14+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-order-om-08-msek-pa-ecorubs-premium-solid-gymmatta/ 2025-06-16T12:54:24+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-conditional-agreement-to-acquire-pharmacure-directed-share-issue-and-updated-financial-targets/ 2025-06-17T10:12:06+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-avsiktsforklaring-loi-med-glenmark-pharmaceuticals-avseende-tyskland-nederlanderna-tjeckien-osterrike-slovakien-och-ukraina/ 2025-06-17T12:56:39+00:00 https://analystgroup.se/kommentarer/kommentar-pa-hedera-groups-uppdatering-kring-affarsinriktningen-life-science/ 2025-06-18T12:40:12+00:00 https://analystgroup.se/kommentarer/kommentar-pa-smolteks-tekniska-serviceavtal-for-smaskalig-produktion-av-cnf-mim-kondensatorer/ 2025-06-18T14:21:50+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-lansering-av-ett-crypto-casino/ 2025-06-19T09:31:33+00:00 https://analystgroup.se/kommentarer/kommentar-pa-mahvie-minerals-starka-analysresultat-fran-haveri/ 2025-06-25T13:33:00+00:00 https://analystgroup.se/kommentarer/kommentar-pa-utfallet-i-circhems-foretradesemission/ 2025-06-30T09:30:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-neovicis-femariga-avtal-med-ledande-svensk-industrikoncern-om-totalt-27-35-msek/ 2025-07-03T06:58:54+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-titania-har-byggstartat-projekt-vid-huddinge-station/ 2025-07-07T12:52:18+00:00 https://analystgroup.se/kommentarer/kommentar-pa-hifabs-q2-rapport/ 2025-07-11T12:27:00+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-positive-study-results-regarding-the-nosa-drug-delivery-platform/ 2025-07-14T08:11:11+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-results-in-icc-2-against-etap/ 2025-07-17T08:54:54+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-nya-order-fran-en-internationell-aktor-inom-rontgenteknik/ 2025-07-21T00:01:32+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-order-om-ca-04-msek-fran-fisica-inc/ 2025-07-24T13:53:41+00:00 https://analystgroup.se/kommentarer/kommentar-pa-obducats-q2-rapport-2/ 2025-07-28T09:41:29+00:00 https://analystgroup.se/kommentarer/comment-on-genetic-analysis-launch-of-ga-map-mhi-guthealth-in-the-usa/ 2025-07-30T08:53:17+00:00 https://analystgroup.se/kommentarer/comment-on-hydrogenpros-partnership-with-thermax-to-indigenise-alkaline-water-electrolysis-solution-for-large-scale-hydrogen-projects/ 2025-08-13T07:39:30+00:00 https://analystgroup.se/kommentarer/kommentar-pa-titanias-q2-rapport/ 2025-08-13T12:32:34+00:00 https://analystgroup.se/kommentarer/kommentar-pa-qlucores-avtal-med-mubadala-health-dubai/ 2025-08-14T12:50:31+00:00 https://analystgroup.se/kommentarer/analyst-group-comments-on-pegs-h1-report-for-2025/ 2025-08-14T12:57:15+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-q2-rapport-5/ 2025-08-14T13:01:33+00:00 https://analystgroup.se/kommentarer/comment-on-hydrogenpros-q2-report-2025/ 2025-08-18T07:35:11+00:00 https://analystgroup.se/kommentarer/comment-on-irisitys-q2-report-for-2025/ 2025-08-18T09:30:34+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-q2-rapport-4/ 2025-08-19T10:11:23+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-q2-report-2025/ 2025-08-21T10:46:02+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-q2-rapport-2025/ 2025-08-21T14:33:58+00:00 https://analystgroup.se/kommentarer/kommentar-pa-first-ventures-q2-rapport-3/ 2025-08-21T20:50:47+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-h1-rapport-for-ar-2025/ 2025-08-22T11:02:38+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-q2-report/ 2025-08-22T12:02:54+00:00 https://analystgroup.se/kommentarer/kommentar-pa-emb-mission-bounds-q2-rapport/ 2025-08-25T07:30:25+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomability-q2-rapport-2025/ 2025-08-25T14:00:31+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-q2-rapport/ 2025-08-27T07:55:35+00:00 https://analystgroup.se/kommentarer/comment-on-genetic-analysis-q2-report-report-2025/ 2025-08-27T12:47:09+00:00 https://analystgroup.se/kommentarer/kommentar-pa-pexas-forsta-hyres-och-datadelningsavtal-i-australien/ 2025-08-27T14:20:59+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-q2-rapport-4/ 2025-08-29T09:39:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tangiamos-q2-rapport-6/ 2025-08-29T12:41:29+00:00 https://analystgroup.se/kommentarer/kommentar-pa-neovicis-q2-rapport/ 2025-09-01T07:14:02+00:00 https://analystgroup.se/kommentarer/comment-on-pharma-equity-groups-regulatory-approval-to-initiate-phase-ii-clinical-trial-for-rnx-011/ 2025-09-01T12:29:30+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-order-till-ukrainska-veteraner/ 2025-09-03T09:58:59+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-titania-tecknar-avtal-om-laneramverk-om-1-665-mdsek/ 2025-09-05T08:11:09+00:00 https://analystgroup.se/kommentarer/analyst-group-comment-on-zeniths-acquisition-of-solar-energy-project/ 2025-09-17T11:20:45+00:00 https://analystgroup.se/kommentarer/analyst-group-comment-on-zeniths-secured-subscription-and-guarantee-commitments/ 2025-09-18T14:07:27+00:00 https://analystgroup.se/kommentarer/analyst-group-comment-on-zeniths-final-submission-in-icsid-arbitration/ 2025-09-22T10:13:38+00:00 https://analystgroup.se/kommentarer/comment-on-irisitys-contract-wins-and-rd-consolidation/ 2025-09-23T08:07:37+00:00 https://analystgroup.se/kommentarer/kommentar-pa-hifabs-nya-strategiska-inriktning-och-namnbyte-till-hultstrom-group/ 2025-09-23T13:30:01+00:00 https://analystgroup.se/kommentarer/comment-on-genetic-analysis-launch-of-ga-map-mhi-guthealth-reagent-kit/ 2025-09-24T08:55:22+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-tvaariga-avtal-med-en-global-aktor-inom-fargindustrin/ 2025-09-25T08:12:11+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tellusgruppens-forslag-om-efterutdelning-motsvarande-en-da-om-23/ 2025-09-30T09:41:42+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-framgangsrika-forsaljning-av-fartyget-perseus/ 2025-09-30T09:46:57+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-erhallna-typgodkannande-av-1-mv-modellen-samt-paborjad-produktion/ 2025-10-01T14:55:24+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-erhallna-order-om-06-msek-pa-specialanpassade-150-kv-ror/ 2025-10-03T09:46:36+00:00 https://analystgroup.se/kommentarer/comment-on-irisitys-fully-guaranteed-rights-issue-of-sek-26m/ 2025-10-06T14:51:50+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-umidas-samarbete-med-finska-influencern-erna-husko/ 2025-10-07T14:54:34+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-agreement-with-apotera-and-launch-in-norway/ 2025-10-07T15:26:24+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-strategiska-samarbete-med-global-industrikoncern/ 2025-10-09T09:25:52+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-investering-i-ett-modernt-bulkfartyg/ 2025-10-10T07:57:56+00:00 https://analystgroup.se/kommentarer/kommentar-pa-hifabs-q3-rapport/ 2025-10-15T11:46:25+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-new-solar-and-battery-storage-acquisition/ 2025-10-15T16:56:08+00:00 https://analystgroup.se/kommentarer/kommentar-pa-dextech-medicals-uppdatering-i-fas-i-studien-avseende-multipelt-myelom/ 2025-10-17T07:20:39+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-accepted-icc-2-annulment-application/ 2025-10-17T15:45:46+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-q3-report-2025/ 2025-10-22T12:50:55+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-framework-agreement-in-norway/ 2025-10-22T13:04:07+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-vunna-upphandlingar-pa-systembolaget/ 2025-10-23T09:55:06+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tellusgruppens-q3-rapport/ 2025-10-24T07:26:44+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-new-solar-acquisitions-and-strategic-update/ 2025-10-28T10:01:26+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-titania-erhaller-byggnadskreditiv-om-975-msek-for-projektet-huddinge-station/ 2025-10-28T12:37:33+00:00 https://analystgroup.se/kommentarer/kommentar-pa-dextechs-q1-rapport-for-ar-2025-26/ 2025-11-03T13:17:18+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-modus-therapeutics-erhaller-godkannande-for-del-2-i-fas-iia-studien-vid-ckd-med-anemi/ 2025-11-04T09:15:24+00:00 https://analystgroup.se/kommentarer/comment-on-irisitys-q3-report-for-2025/ 2025-11-04T10:03:27+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-avsiktsforklaring-med-fisica/ 2025-11-04T15:09:35+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-titania-tecknar-avtal-om-forvarv-av-projekt-med-500-bostader-i-masmo/ 2025-11-05T15:08:18+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-legal-decision-from-the-paris-commercial-court/ 2025-11-05T17:25:52+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-q3-report/ 2025-11-07T14:08:24+00:00 https://analystgroup.se/kommentarer/kommentar-pa-first-ventures-q3-rapport-4/ 2025-11-07T14:16:22+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-inlamnade-edf-ansokan/ 2025-11-11T08:50:32+00:00 https://analystgroup.se/kommentarer/kommentar-pa-mahvie-minerals-q3-rapport/ 2025-11-11T12:41:30+00:00 https://analystgroup.se/kommentarer/kommentar-pa-circhems-q3-rapport-5/ 2025-11-12T14:04:50+00:00 https://analystgroup.se/kommentarer/kommentar-pa-titanias-q3-rapport/ 2025-11-13T14:07:49+00:00 https://analystgroup.se/kommentarer/comment-on-hydrogenpros-q3-report-2025/ 2025-11-14T15:14:43+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-q3-rapport-2025/ 2025-11-17T08:59:48+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-q3-rapport-4/ 2025-11-17T09:06:35+00:00 https://analystgroup.se/kommentarer/comment-on-genetic-analysis-announced-milestone-regarding-ga-map-ibd-precision-dx/ 2025-11-17T13:37:39+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-acquisition-of-canngros-aps/ 2025-11-18T11:15:56+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-strategic-entry-into-the-uranium-sector-and-latest-solar-acquisition/ 2025-11-18T15:26:18+00:00 https://analystgroup.se/kommentarer/comment-on-the-outcome-of-irisitys-rights-issue-2/ 2025-11-21T15:24:00+00:00 https://analystgroup.se/kommentarer/kommentar-pa-emb-mission-bounds-q3-rapport/ 2025-11-24T08:49:03+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomability-q3-rapport-2025/ 2025-11-24T13:25:33+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-nre-order-fran-fisica/ 2025-11-24T14:11:57+00:00 https://analystgroup.se/kommentarer/kommentar-pa-modus-therapeutics-q3-rapport/ 2025-11-26T12:25:37+00:00 https://analystgroup.se/kommentarer/analyst-group-comment-on-zeniths-construction-tender-launch-in-puglia/ 2025-11-26T13:44:50+00:00 https://analystgroup.se/kommentarer/comment-on-genetic-analysis-q3-report-report-2025/ 2025-11-27T12:36:52+00:00 https://analystgroup.se/kommentarer/analyst-group-comment-on-zeniths-update-on-unauthorised-sale-of-tunisian-crude-oil/ 2025-11-28T08:03:57+00:00 https://analystgroup.se/kommentarer/kommentar-pa-titanias-genomforda-riktade-nyemission-om-79-msek/ 2025-11-28T14:25:38+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ecorubs-q3-rapport-3/ 2025-11-28T14:38:03+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-q3-rapport-2/ 2025-12-01T08:33:54+00:00 https://analystgroup.se/kommentarer/kommentar-pa-neovicis-q3-rapport/ 2025-12-01T10:32:21+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-samtliga-patienter-svarat-positivt-pa-osteodex-i-dextech-medicals-fas-i-studie-avseende-multipelt-myelom/ 2025-12-03T13:37:26+00:00 https://analystgroup.se/kommentarer/analyst-group-inleder-analysbevakning-av-pila-pharma/ 2025-12-05T09:28:56+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-hittills-storsta-order-pa-zeqmelit/ 2025-12-08T09:55:35+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-completion-of-private-placement/ 2025-12-08T11:58:39+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tellusgruppens-preliminara-resultat-for-oktober-2025/ 2025-12-09T12:25:09+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-modus-therapeutics-har-doserat-forsta-patienten-i-del-2-av-fas-iia-studien-vid-kronisk-njursjukdom-med-anemi/ 2025-12-10T15:59:34+00:00 https://analystgroup.se/kommentarer/comment-on-pharma-equity-groups-letter-of-intent-to-acquire-medtech-company-otiom-a-s/ 2025-12-11T09:15:29+00:00 https://analystgroup.se/kommentarer/kommentar-pa-mahvie-minerals-identifierade-radata-i-haveri/ 2025-12-12T01:06:21+00:00 https://analystgroup.se/kommentarer/comment-on-that-a-long-term-study-shows-improved-quality-of-life-with-nosa-plugs-smell-training-kit-smell-training/ 2025-12-12T09:39:27+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-lyckade-tester-och-inledda-serieproduktion-av-zoom-2-0/ 2025-12-16T08:11:14+00:00 https://analystgroup.se/kommentarer/comment-on-that-nosa-plugs-product-odor-control-has-been-procured-in-marseille-france/ 2025-12-17T16:06:25+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-pila-pharma-har-initierat-prekliniska-studier-inom-obesitas/ 2025-12-19T12:07:28+00:00 https://analystgroup.se/kommentarer/kommentar-pa-neovicis-nya-strategiska-avtal-med-befintlig-kund/ 2025-12-19T12:32:44+00:00 https://analystgroup.se/kommentarer/comment-on-pharma-equity-groups-strategic-update-and-adjustment-of-expectations/ 2025-12-30T13:27:22+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-investering-i-ett-kamsarmax-torrbulksfartyg/ 2026-01-08T14:32:06+00:00 https://analystgroup.se/kommentarer/analyst-group-inleder-analysbevakning-av-lumito/ 2026-01-12T12:39:12+00:00 https://analystgroup.se/kommentarer/kommentar-pa-obducats-order-om-48-msek-som-omfattar-fotolitografiutrustning-fran-nxq/ 2026-01-19T15:39:37+00:00 https://analystgroup.se/kommentarer/kommentar-pa-mahvie-minerals-riktade-nyemission-och-toppgarantiatagande-infor-to2/ 2026-01-20T13:35:49+00:00 https://analystgroup.se/kommentarer/kommentar-pa-emb-mission-bounds-avsiktsforklaring-om-forvarv-av-megabet-plus/ 2026-01-21T09:08:33+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-avtal-med-glenmark-pharmaceuticals-avseende-kommersialisering-av-zeqmelit-i-sex-europeiska-lander/ 2026-01-22T10:52:14+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-starka-efterfragan-pa-zoom-2-0-och-slutsald-forsta-delbatch/ 2026-01-22T12:57:25+00:00 https://analystgroup.se/kommentarer/kommentar-pa-pila-pharmas-preklinska-studieresultat-inom-obesitas-samt-signering-av-ett-avtal-med-en-ny-cro-avseende-kliniska-studier/ 2026-01-26T22:36:51+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-samtliga-patienter-svarat-positivt-pa-osteodex-i-dextech-medicals-fas-i-iia-studie-avseende-multipelt-myelom/ 2026-01-27T11:19:32+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-partnership-with-weeco-and-launch-of-a-new-astrum-oil-product-in-germany/ 2026-01-28T08:23:50+00:00 https://analystgroup.se/kommentarer/kommentar-pa-utfallet-i-scibase-foretradesemission-samt-beslut-om-kvittningsemission-hanforligt-till-aterkopserbjudandet-av-to2/ 2026-01-28T08:47:42+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-receiving-positive-organ-data-from-an-in-vivo-study/ 2026-01-29T11:01:29+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-bokslutskommunike-for-ar-2025/ 2026-01-30T11:06:21+00:00 https://analystgroup.se/kommentarer/comment-on-circio-holdings-oversubscribed-rights-issue/ 2026-02-02T08:35:18+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-erhallna-order-om-05-msek-for-specialanpassade-300-kv-ror/ 2026-02-03T09:14:18+00:00 https://analystgroup.se/kommentarer/kommentar-pa-titanias-genomforda-forsaljning-av-byggratt-for-52-msek/ 2026-02-04T10:23:14+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lumitos-pilotprojekt-samt-erhallna-ordrar/ 2026-02-04T22:52:37+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tellusgruppens-bokslutskommunike-2025/ 2026-02-06T07:47:45+00:00 https://analystgroup.se/kommentarer/kommentar-pa-pila-pharmas-h2-rapport/ 2026-02-10T15:48:36+00:00 https://analystgroup.se/kommentarer/comment-on-pila-pharmas-h2-report/ 2026-02-10T15:49:29+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-partnership-with-icmf-and-product-filing-in-france/ 2026-02-11T08:22:06+00:00 https://analystgroup.se/kommentarer/analyst-group-comment-on-polights-follow-on-tlens-order-supporting-consumer-oem-qualification/ 2026-02-11T15:01:45+00:00 https://analystgroup.se/kommentarer/kommentar-pa-jolucas-nya-listningar-hos-coop/ 2026-02-11T15:16:23+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-q4-report/ 2026-02-13T12:29:56+00:00 https://analystgroup.se/kommentarer/kommentar-pa-neovicis-riktad-nyemission-om-10-msek-till-peter-gyllenhammar-ab/ 2026-02-13T13:34:41+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-strategiska-samarbete-med-ijustwanttobecool-och-etablerar-gemensamt-bolag-for-snacks/ 2026-02-16T20:00:05+00:00 https://analystgroup.se/kommentarer/kommentar-pa-mahvie-minerals-q4-rapport/ 2026-02-17T14:04:57+00:00 https://analystgroup.se/kommentarer/analyst-group-kommenterar-nya-kliniska-data-fran-scibase-med-implikationer-for-barriarsegmentet/ 2026-02-17T16:14:58+00:00 https://analystgroup.se/kommentarer/kommentar-pa-utfallet-av-pila-pharmas-teckningsoptioner-av-serie-to2/ 2026-02-18T08:13:32+00:00 https://analystgroup.se/kommentarer/comment-on-the-outcome-of-pila-pharmas-series-to2-warrants/ 2026-02-18T08:14:19+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-scibases-nevisense-eis-inkluderas-i-nccns-amerikanska-kliniska-riktlinjer-for-melanom/ 2026-02-19T14:09:23+00:00 https://analystgroup.se/kommentarer/kommentar-pa-umidas-q4-rapport-2025/ 2026-02-20T08:21:38+00:00 https://analystgroup.se/kommentarer/kommentar-pa-titanias-q4-rapport-2/ 2026-02-20T14:49:57+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lumitos-bokslutskommunike-2025/ 2026-02-20T15:16:35+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-q4-rapport-5/ 2026-02-23T09:43:05+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomability-q4-rapport-2025/ 2026-02-23T11:17:54+00:00 https://analystgroup.se/kommentarer/comment-on-polights-q4-25-report/ 2026-02-24T14:37:11+00:00 https://analystgroup.se/kommentarer/kommentar-pa-modus-therapeutics-q4-rapport/ 2026-02-25T10:51:55+00:00 https://analystgroup.se/kommentarer/kommentar-pa-dextechs-q2-rapport-for-ar-2025-26/ 2026-02-25T14:10:29+00:00 https://analystgroup.se/kommentarer/comment-on-circio-holdings-new-in-vivo-eye-data-showing-50-fold-enhanced-aav-circvec-expression-vs-conventional-mrna-based-aavs/ 2026-02-26T12:42:33+00:00 https://analystgroup.se/kommentarer/comment-on-stenocares-q4-report-2025/ 2026-02-26T14:55:02+00:00 https://analystgroup.se/kommentarer/kommentar-pa-neovicis-q4-rapport-2/ 2026-02-27T11:33:24+00:00 https://analystgroup.se/kommentarer/comment-on-genetic-analysis-q4-report-report-2025/ 2026-02-27T12:41:19+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-tre-erhallna-order-om-totalt-07-msek/ 2026-02-27T14:51:38+00:00 https://analystgroup.se/kommentarer/comment-on-hydrogenpros-q4-report-2025/ 2026-02-27T15:58:32+00:00 https://analystgroup.se/kommentarer/kommentar-pa-scibases-breddade-fda-godkannande-for-nevisense-i-usa/ 2026-03-02T09:52:11+00:00 https://analystgroup.se/kommentarer/kommentar-pa-ramlosa-shippings-q4-rapport-2/ 2026-03-02T20:28:16+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-solar-acquisition-and-gas-supply-growth/ 2026-03-05T10:46:49+00:00 https://analystgroup.se/kommentarer/kommenterar-pa-acucorts-deltagande-vid-partneringkonferensen-bio-europe-spring/ 2026-03-05T12:13:54+00:00 https://analystgroup.se/kommentarer/comment-on-genetic-analysis-launch-of-ga-map-dysbiosis-test-ainsight/ 2026-03-12T10:35:16+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lumitos-pilotstudie-med-offspring-biosciences/ 2026-03-12T13:02:41+00:00 https://analystgroup.se/kommentarer/kommentar-pa-scibase-bokslutskommunike-2025/ 2026-03-13T13:54:08+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lumitos-proof-of-concept-studie-med-tethis-s-p-a/ 2026-03-18T09:50:24+00:00 https://analystgroup.se/kommentarer/comment-on-circio-holdings-selection-for-oral-presentation-at-asgct-2026/ 2026-03-18T16:25:06+00:00 https://analystgroup.se/kommentarer/comment-on-irisitys-q4-report-for-2025/ 2026-03-19T15:35:03+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-increase-in-solar-development-pipeline-to-173-5-mwp-and-update-on-italian-electricity-production/ 2026-03-23T10:37:07+00:00 https://analystgroup.se/kommentarer/analyst-group-inleder-analysbevakning-av-synexo-group/ 2026-03-25T08:18:12+00:00 https://analystgroup.se/kommentarer/kommentar-pa-tellusgruppens-forvarv-av-danderyds-enskilda-skola-ab/ 2026-03-26T11:23:18+00:00 https://analystgroup.se/kommentarer/kommentar-pa-mahvie-minerals-mineraltillgangsbedomning-i-haveri/ 2026-03-26T13:12:26+00:00 https://analystgroup.se/kommentarer/comment-on-circios-in-vivo-car-m-collaboration-with-united-immunity/ 2026-03-26T16:00:15+00:00 https://analystgroup.se/kommentarer/kommentar-pa-emb-mission-bounds-q4-rapport-2/ 2026-03-27T12:10:07+00:00 https://analystgroup.se/kommentarer/kommentar-pa-zoomabilitys-fulltecknade-andra-delbatch-och-okade-marknadsintresse-for-zoom-2-0/ 2026-03-27T13:41:13+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lumitos-pilotprojekt-med-oraclebio/ 2026-04-02T09:06:16+00:00 https://analystgroup.se/kommentarer/kommentar-pa-luxbrights-annonserade-emissioner-om-totalt-ca-195-msek/ 2026-04-07T12:30:48+00:00 https://analystgroup.se/kommentarer/comment-on-polights-follow-on-tlens-purchase-order-for-consumer-armr-application/ 2026-04-08T07:25:25+00:00 https://analystgroup.se/kommentarer/comment-on-circios-nok-250m-private-placement-and-subsequent-offering-of-nok-82-5m/ 2026-04-08T09:50:50+00:00 https://analystgroup.se/kommentarer/kommentar-pa-lumitos-forsta-cro-genererade-intakter-genom-samarbetet-med-truly-labs/ 2026-04-09T08:37:28+00:00 https://analystgroup.se/kommentarer/comment-on-nosa-plugs-launch-of-the-full-consumer-portfolio-on-the-french-pharmacy-market/ 2026-04-13T07:19:40+00:00 https://analystgroup.se/kommentarer/kommentar-pa-acucorts-overenskommelse-med-fda-avseende-ipsp/ 2026-04-13T09:48:07+00:00 https://analystgroup.se/kommentarer/kommentar-pa-synexos-marsuppdatering/ 2026-04-13T14:31:42+00:00 https://analystgroup.se/kommentarer/kommentar-pa-synexos-forvarv-av-deploi/ 2026-04-14T09:34:44+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-update-on-tunisias-recognition-of-crude-oil-ownership/ 2026-04-14T09:44:30+00:00 https://analystgroup.se/kommentarer/kommentar-pa-att-kdventures-nyttjar-samtliga-sina-to2-i-modus-therapeutics/ 2026-04-15T07:50:01+00:00 https://analystgroup.se/kommentarer/kommentar-pa-pila-pharmas-bekraftelse-om-att-lag-exponering-av-xen-d0501-sannolikt-resulterade-i-avsaknad-av-effekt-i-prekliniska-obesitasstudier/ 2026-04-17T06:57:28+00:00 https://analystgroup.se/kommentarer/comment-on-circios-fy2025-report-platform-validation-and-a-transformational-financing-set-the-stage-for-a-pivotal-2026/ 2026-04-17T07:15:24+00:00 https://analystgroup.se/kommentarer/kommenterar-jolucas-lansering-av-vatskeersattning-hos-apoteket-ab/ 2026-04-21T12:29:55+00:00 https://analystgroup.se/kommentarer/kommentar-pa-synexos-foretradesemission-om-cirka-44-msek-for-finansiering-av-forvarvsstrategin/ 2026-04-21T13:49:16+00:00 https://analystgroup.se/kommentarer/comment-on-zeniths-acquisition-of-photovoltaic-development-project-in-puglia/ 2026-04-23T13:24:45+00:00 https://analystgroup.se/kommentarer/preview-comment-on-polights-q1-26-interim-report/ 2026-04-23T14:02:11+00:00